Asakimori Y - Search Results

1

Two cases of hypothyroidism complicated by renal dysfunction.

Ogata S, Yorioka N, Tanji C, Asakimori Y, Ito T, Masaki T, Nishida Y, Taniguchi Y, Yamakido M. Ogata S, et al. Among authors: asakimori y. Hiroshima J Med Sci. 2000 Mar;49(1):93-6. Hiroshima J Med Sci. 2000. PMID: 10824462

2

A case of aortitis syndrome and IgA nephropathy: possible role of human leukocyte antigens in both diseases.

Kanahara K, Yorioka N, Ogata S, Ohira N, Oobayashi M, Kiso T, Harada Y, Komiya H, Asakimori Y, Taniguchi Y, Yamakido M. Kanahara K, et al. Among authors: asakimori y. Hiroshima J Med Sci. 1999 Mar;48(1):25-9. Hiroshima J Med Sci. 1999. PMID: 10213960

3

Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy.

Taniguchi Y, Yorioka N, Masaki T, Asakimori Y, Yamashita K, Yamakido M. Taniguchi Y, et al. Among authors: asakimori y. Scand J Urol Nephrol. 1999 Aug;33(4):243-7. doi: 10.1080/003655999750015853. Scand J Urol Nephrol. 1999. PMID: 10515087

4

Dose-dependent effect of an oral adsorbent, AST-120, in patients with early chronic renal failure.

Yorioka N, Ito T, Masaki T, Ogata S, Asakimori Y, Tanji C, Kyuden Y, Komiya Y, Kumagai J, Taniguchi Y, Kohno N. Yorioka N, et al. Among authors: asakimori y. J Int Med Res. 2002 Sep-Oct;30(5):467-75. doi: 10.1177/147323000203000501. J Int Med Res. 2002. PMID: 12449515 Free article.

5

Reiter's syndrome associated with HLA-B51: a case report.

Taniguchi Y, Yorioka N, Kyuden Y, Asakimori Y. Taniguchi Y, et al. Among authors: asakimori y. J Int Med Res. 2003 Jan-Feb;31(1):55-7. doi: 10.1177/147323000303100109. J Int Med Res. 2003. PMID: 12635535 Free article.

6

T(-786)-->C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease.

Asakimori Y, Yorioka N, Taniguchi Y, Ito T, Ogata S, Kyuden Y, Kohno N. Asakimori Y, et al. Nephron. 2002 Aug;91(4):747-51. doi: 10.1159/000065041. Nephron. 2002. PMID: 12138283

7

Gastric antral vascular ectasia in a patient on hemodialysis improved with CAPD.

Yorioka N, Hamaguchi N, Taniguchi Y, Asakimori Y, Nishiki T, Oda H, Yamakido M. Yorioka N, et al. Among authors: asakimori y. Perit Dial Int. 1996 Mar-Apr;16(2):177-8. Perit Dial Int. 1996. PMID: 9147554 No abstract available.

8

Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease.

Asakimori Y, Yorioka N, Yamamoto I, Okumoto S, Doi S, Hirai T, Taniguchi Y. Asakimori Y, et al. Nephron. 2001 Oct;89(2):219-23. doi: 10.1159/000046071. Nephron. 2001. PMID: 11549906

9

Bone mineral density may be related to atherosclerosis in hemodialysis patients.

Nakashima A, Yorioka N, Tanji C, Asakimori Y, Ago R, Usui K, Shigemoto K, Harada S. Nakashima A, et al. Among authors: asakimori y. Osteoporos Int. 2003 Jun;14(5):369-73. doi: 10.1007/s00198-002-1361-4. Epub 2003 May 24. Osteoporos Int. 2003. PMID: 12768278

10

Different risk factors for the maximum and the mean carotid intima-media thickness in hemodialysis patients.

Nakashima A, Yorioka N, Asakimori Y, Ito T, Masaki T, Shigemoto K, Harada S. Nakashima A, et al. Among authors: asakimori y. Intern Med. 2003 Nov;42(11):1095-9. doi: 10.2169/internalmedicine.42.1095. Intern Med. 2003. PMID: 14686748 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters